Lysosomes as a therapeutic target

Srinivasa Reddy Bonam(Centre National de la Recherche Scientifique), Sylviane Muller(Centre National de la Recherche Scientifique)

Nature Reviews Drug Discovery

September 2, 2019

10.1038/s41573-019-0036-1

Cited by 751

Related Papers

Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo

|Cells|2020|44

Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases

|Journal of Autoimmunity|2022|23

An Autophagy Modulator Peptide Prevents Lung Function Decrease and Corrects Established Inflammation in Murine Models of Airway Allergy

|Cells|2021|17

Long COVID-19 autoantibodies and their potential effect on fertility

|Frontiers in Immunology|2025|4